Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Applications of pterostilbene in preparation of medicines for preventing and treating chronic glomerular disease

A technology of glomerular disease and pterostilbene, which is applied in the application field of pterostilbene in the preparation of drugs for the prevention and treatment of chronic glomerular diseases, can solve the problems of limited improvement effect and obvious side effects, and achieve clear regulation effect and clear ingredients , targeted effects

Active Publication Date: 2012-12-26
NANJING UNIV
View PDF1 Cites 4 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The improvement effects of the above drugs are limited, and the side effects are obvious

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Applications of pterostilbene in preparation of medicines for preventing and treating chronic glomerular disease
  • Applications of pterostilbene in preparation of medicines for preventing and treating chronic glomerular disease
  • Applications of pterostilbene in preparation of medicines for preventing and treating chronic glomerular disease

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0027] Example 1: The therapeutic effect of pterostilbene on glomerular lesions in fructose model rats.

[0028] Experimental animals: SD rats, 200-220 grams, male.

[0029] Drug preparation: select tablets for the prevention or treatment of glomerular diseases with a pterostylbene content of 40 mg / tablet, ultrasonically disperse them in normal saline, and use them for intragastric administration with a dosage of 40 mg / kg.

[0030] Experimental instruments: high-speed refrigerated centrifuge, tissue slicer, microplate reader, optical microscope, transmission electron microscope, etc.

[0031] experimental method:

[0032] 1. Establishment of the model: After adapting to the environment for one week, the animals were randomly divided into a model group and a normal group, with 30 animals in each group. Modeling of fructose rat model: Drinking water was given 10% fructose solution; normal group was given tap water, and the modeling period was 70 days.

[0033] 2. After 4 week...

Embodiment 2

[0047] Dissolve pterostilbene in water and an appropriate amount of solubilizer (polyethylene glycol 400) according to the conventional preparation method, subpackage, and sterilize to prepare an oral liquid for the prevention or treatment of glomerular diseases with a pterostilbene content of 20 mg / ml;

[0048] Pterostilbene is prepared according to conventional preparation methods, gelatin and sorbitol are selected as soft capsule materials, and the content of pterostilbene is 20mg / capsules for the prevention or treatment of glomerular diseases;

[0049]Pterostilbene is added with excipient cyclodextrin according to the conventional preparation method, mixed uniformly, granulated, and tabletted to prepare tablets for the prevention and treatment of glomerular diseases with a content of pterostilbene of 20 mg / tablet.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to new medical applications of a natural monomer compound pterostilbene, in particular to applications of the pterostilbene in preparation of medicines for preventing and treating a chronic glomerular disease, and applications of pterostilbene in preparation of medicines for preventing and treating progressive chronic glomerular disease. Animal test results show that the pterostilbene has an obvious effect on prevention and improvement of a glomerular function and an organic injury of a fructose model rat renal. The pterostilbene is matched up with relevant adjuvants, a conventional preparation method can be utilized to obtain a health care product or a medicine aiming at preventing and treating the glomerular disease. The above health care product and the medicine can be used for the diseases relevant to the chronic glomerular lesion, such as diabetes and metabolic syndrome and the like, so that the glomerular progressive course in the relevant diseases can be delayed and improved.

Description

1. Technical field: [0001] The present invention relates to a new medical application of natural plant active ingredient pterostilbene, in particular to the application of pterostilbene in the preparation of drugs for the prevention and treatment of chronic glomerular diseases, especially for the preparation of drugs for progressive chronic glomerular diseases Application in preventive and therapeutic agents. 2. Background technology: [0002] Pterostilbene (Pterostilbene, CAS No. 537-42-8), is a natural active ingredient that belongs to resveratrol derivatives, and is used in grapes, blue strawberries, dried blood products, Indian jina trees and Indian anti-diabetic herbal medicine "Bijasar". "The important active ingredient in. [0003] The prevalence of diabetes in China is 9.7%, which is higher than the world average of 6.4%, and China has become the world's largest diabetic country. There are as many as 150 million people at high risk of diabetes in my country. With ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K31/09A61P13/12
Inventor 孔令东王伟潘颖丁晓琴
Owner NANJING UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com